Clin Infect Dis 100 Days of COVID-19 Prevention and Control in China

[tetano]

Clin Infect Dis


. 2020 Jun 5;ciaa725.
doi: 10.1093/cid/ciaa725. Online ahead of print.
100 Days of COVID-19 Prevention and Control in China


Lei Zhou ¹ , Zunyou Wu ¹ , Zhongjie Li ¹ , Yanping Zhang ¹ , Jennifer M McGoogan ¹ , Qun Li ¹ , Xiaoping Dong ¹ , Ruiqi Ren ¹ , Luzhao Feng ¹ , Xiaopeng Qi ¹ , Jingjing Xi ¹ , Ying Cui ¹ , Wenjie Tan ¹ , Guoqing Shi ¹ , Guizhen Wu ¹ , Wenbo Xu ¹ , Xiaoqi Wang ¹ , Jiaqi Ma ¹ , Xuemei Su ¹ , Zijian Feng ¹ , George F Gao ¹ , China COVID-19 Task Force



Affiliations

• PMID: 32502263
• DOI: 10.1093/cid/ciaa725

Abstract

The epidemic of novel coronavirus diseases was first reported in China in late December 2019 and has been brought under control after some two months in China. However, it has become a global pandemic and the number of cases and deaths continues to increase outside of China. We describe the emergence of the pandemic, detail the first 100 days of China's response as a Phase 1 Containment followed by Phase 2 Containment strategy, and briefly highlight areas of focus for the future. Specific, simple, and pragmatic strategies used in China for risk assessment, prioritization, and deployment of resources are described. Details of implementation, at different risk levels, of the traditional public health interventions are shared. Involvement of society in mounting a whole country response and challenges experienced with logistics and supply chains are described. Finally, the methods China is employing to cautiously re-start social life and economic activity are outlined.